Escherichia (O104:H4) Individual Microorganism, E. Coli, ATCC Baa-2326, Lyfo Disk Lyophilized Pellets with Epower Certified Reference Material (CRM), 10 per Vial - 01104E3

Escherichia (O104:H4) Individual Microorganism, E. Coli, ATCC Baa-2326, Lyfo Disk Lyophilized Pellets with Epower Certified Reference Material (CRM), 10 per Vial

Choose the Escherichia (O104:H4) Individual Microorganism, E. Coli, ATCC Baa-2326, Lyfo Disk Lyophilized Pellets with Epower Certified Reference Material (CRM), 10 per Vial where consistent quality and simple reordering matter. E.coli ATCC BAA-2326.

Key Features

• Clinical laboratories are the front line in detecting Shiga toxin-producing Escherichia coli (Stec) disease.
• They are responsible for the initial detection of suspect cases by testing primary specimens.
• The Centers for Disease Control (CDC) recommends that, "All stools submitted for testing from patients with acute community-acquired diarrhea should be cultured for Stec O157.
• These stools should be simultaneously assayed for non-O157 Stec with a test that detects Shiga toxins or the genes encoding these toxins".
• Microbiologics is the world's first and only supplier to offer O157 and non-O157 Shiga toxin-producing E. coli (Stec) in easy-to-use, prepared formats for quality control testing.
• Clinical testing laboratories can utilize Stec QC microorganisms from Microbiologics to validate, verify and perform routine quality control checks of their Stec test methods.

Specifications